Yuan, J. et al. Novel technologies and emerging biomarkers for personalized cancer immunotherapy. J. Immunother. Cancer 4, 3 (2016).
Connors, J. et al. Using the power of innate immunoprofiling to understand vaccine design, infection, and immunity. Hum. Vaccines Immunother. 19, 2267295 (2023).
Ogunniyi, A. O. et al. Profiling human antibody responses by integrated single-cell analysis. Vaccine 32, 2866–2873 (2014).
Stork, E. M. et al. Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis. Nat. Commun. 15, 3114 (2024).
Lu, R. M. et al. Development of therapeutic antibodies for the treatment of diseases. J. Biomed. Sci. 27, 1 (2020).
Deshaies, R. J. Multispecific drugs herald a new era of biopharmaceutical innovation. Nature 580, 329–338 (2020).
Zhong, X., D’antona, A. M., Karagiannis, S. & White, A. Recent advances in the molecular design and applications of multispecific biotherapeutics. Antibodies 10, 13 (2021).
Weiner, G. J. Building better monoclonal antibody-based therapeutics. Nat. Rev. Cancer 15, 361–370 (2015).
Gérard, A. et al. High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics. Nat. Biotechnol. 38, 715–721 (2020).
Muruato, A. E. et al. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nat. Commun. 11, 4059 (2020).
Tickle, S. et al. High-throughput screening for high affinity antibodies. J. Lab. Autom. 14, 303–307 (2009).
Schofield, D. J. et al. Application of phage display to high throughput antibody generation and characterization. Genome Biol. 8, R254 (2007).
Carlson, E. D., Gan, R., Hodgman, C. E. & Jewett, M. C. Cell-free protein synthesis: applications come of age. Biotechnol. Adv. 30, 1185–1194 (2012).
Cubillos-Ruiz, A. et al. Engineering living therapeutics with synthetic biology. Nat. Rev. Drug Discov. 20, 941–960 (2021).
Gu, Y. et al. Cell-free protein synthesis system for bioanalysis: advances in methods and applications. Trends Anal. Chem. 161, 117015 (2023).
Slomovic, S., Pardee, K. & Collins, J. J. Synthetic biology devices for in vitro and in vivo diagnostics. Proc. Natl Acad. Sci. USA 112, 14429–14435 (2015).
Murray, C. J. & Baliga, R. Cell-free translation of peptides and proteins:from high throughput screening to clinical production. Curr. Opin. Chem. Biol. 17, 420–426 (2013).
Ramm, F. et al. Mammalian cell-free protein expression promotes the functional characterization of the tripartite non-hemolytic enterotoxin from Bacillus cereus. Sci. Rep. 10, 2887 (2020).
Thoring, L. et al. Cell-free systems based on CHO cell lysates: optimization strategies, synthesis of “difficult-to-express” proteins and future perspectives. PLoS ONE 11, e0163670 (2016).
Garenne, D., Bowden, S. & Noireaux, V. Cell-free expression and synthesis of viruses and bacteriophages: applications to medicine and nanotechnology. Curr. Opin. Syst. Biol. 28, 100373 (2021).
Sullivan, C. J. et al. A cell-free expression and purification process for rapid production of protein biologics. Biotechnol. J. 11, 238–248 (2016).
Pardee, K. et al. Rapid, low-cost detection of Zika virus using programmable biomolecular components. Cell 165, 1255–1266 (2016).
Silverman, A. D., Akova, U., Alam, K. K., Jewett, M. C. & Lucks, J. B. Design and optimization of a cell-free atrazine biosensor. ACS Synth. Biol. 9, 671–677 (2020).
Wen, K. Y. et al. A cell-free biosensor for detecting quorum sensing molecules in P. aeruginosa-infected respiratory samples. ACS Synth. Biol. 6, 2293–2301 (2017).
Hunt, A. C. et al. A rapid cell-free expression and screening platform for antibody discovery. Nat. Commun. 14, 3897 (2023).
Ojima-Kato, T., Nagai, S. & Nakano, H. Ecobody technology: rapid monoclonal antibody screening method from single B cells using cell-free protein synthesis for antigen-binding fragment formation. Sci. Rep. 7, 13979 (2017).
Stech, M. & Kubick, S. Cell-free synthesis meets antibody production: a review. Antibodies 4, 12–33 (2015).
Ramachandran, N. et al. Self-assembling protein microarrays. Science 305, 86–90 (2004).
Gerber, D., Maerkl, S. J. & Quake, S. R. An in vitro microfluidic approach to generating protein-interaction networks. Nat. Methods 6, 71–74 (2009).
Blackburn, M. C., Petrova, E., Correia, B. E. & Maerkl, S. J. Integrating gene synthesis and microfluidic protein analysis for rapid protein engineering. Nucleic Acids Res. 44, e68 (2015).
Markin, C. J. et al. Revealing enzyme functional architecture via high-throughput microfluidic enzyme kinetics. Science 373, eabf8761 (2021).
Norouzi, M. et al. Cell-free dot blot: an ultra-low-cost and practical immunoassay platform for detection of anti-SARS-CoV-2 antibodies in human and animal sera. Microbiol. Spectr. 11, e0245722 (2023).
Hufnagel, K. et al. In situ, cell-free protein expression on microarrays and their use for the detection of immune responses. Bio-protocol 9, e3152 (2019).
Goshima, N. et al. Human protein factory for converting the transcriptome into an in vitro-expressed proteome. Nat. Methods 5, 1011–1017 (2008).
Morishita, R. et al. CF-PA2Vtech: a cell-free human protein array technology for antibody validation against human proteins. Sci. Rep. 9, 19349 (2019).
Levy, M., Falkovich, R., Daube, S. S. & Bar-Ziv, R. H. Autonomous synthesis and assembly of a ribosomal subunit on a chip. Sci. Adv. 6, eaaz6020 (2020).
Vonshak, O. et al. Programming multi-protein assembly by gene-brush patterns and two-dimensional compartment geometry. Nat. Nanotechnol. 15, 783–791 (2020).
Buxboim, A. et al. A single-step photolithographic interface for cell-free gene expression and active biochips. Small 3, 500–510 (2007).
Bracha, D. et al. Entropy-driven collective interactions in DNA brushes on a biochip. Proc. Natl Acad. Sci. USA 110, 4534–4538 (2013).
Förste, S. et al. Computational analysis of protein synthesis, diffusion, and binding in compartmental biochips. Microb. Cell Fact. 22, 244 (2023).
Buxboim, A., Daube, S. S. & Bar-Ziv, R. Synthetic gene brushes: a structure–function relationship. Mol. Syst. Biol. 4, 181 (2008).
Caschera, F. & Noireaux, V. Synthesis of 2.3 mg/ml of protein with an all Escherichia coli cell-free transcription–translation system. Biochimie 99, 162–168 (2014).
Zhang, S., Garcia-D’Angeli, A., Brennan, J. P. & Huo, Q. Predicting detection limits of enzyme-linked immunosorbent assay (ELISA) and bioanalytical techniques in general. Analyst 139, 439–445 (2013).
Seydoux, E. et al. Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation. Immunity 53, 98–105.e5 (2020).
Ter Meulen, J. et al. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med. 3, 1071–1079 (2006).
Gong, Y., Qin, S. & Dai, L. The glycosylation in SARS-CoV-2 and its receptor ACE2. Signal Transduct. Target. Ther. 6, 396 (2021).
Telenti, A., Hodcroft, E. B. & Robertson, D. L. The evolution and biology of SARS-CoV-2 variants. Cold Spring Harb. Perspect. Med. 12, a041390 (2022).
Huang, M. et al. Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape. Immunity 55, 1501–1514 (2022).
Lee, C. H. et al. Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains. Front. Immunol. 11, 579480 (2020).
Wu, W., Cheng, Y., Zhou, H., Sun, C. & Zhang, S. The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics. Virol. J. 20, 6 (2023).
Movsisyan, M. et al. Tracking the evolution of anti-SARS-CoV-2 antibodies and long-term humoral immunity within 2 years after COVID-19 infection. Sci. Rep. 14, 13417 (2024).
Kightlinger, W. et al. A cell-free biosynthesis platform for modular construction of protein glycosylation pathways. Nat. Commun. 10, 5404 (2019).
Marani, M., Katul, G. G., Pan, W. K. & Parolari, A. J. Intensity and frequency of extreme novel epidemics. Proc. Natl Acad. Sci. USA 118, e2105482118 (2021).
Hurlburt, N. K. et al. Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation. Nat. Commun. 11, 5413 (2020).
Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009).
Buxboim, A., Daube, S. S. & Bar-Ziv, R. Ultradense synthetic gene brushes on a chip. Nano Lett. 9, 909–913 (2009).
Garamella, J., Marshall, R., Rustad, M. & Noireaux, V. The all E. coli TX-TL Toolbox 2.0: a platform for cell-free synthetic biology. ACS Synth. Biol. 5, 344–355 (2016).
He, B. et al. Rapid mutagenesis and purification of phage RNA polymerases. Protein Expr. Purif. 9, 142–151 (1997).
Yu, T., Laird, J. R., Prescher, J. A. & Thorpe, C. Gaussia princeps luciferase: a bioluminescent substrate for oxidative protein folding. Protein Sci. 27, 1509–1517 (2018).
Dupin, A. Cell-free immuno-profiling on a genetically programmed biochip. Zenodo (2025).
